(Q37278983)

19 August 2017

1 reference

title

Bladder cancer: clinical and pathological profile (English)

1 reference

19 August 2017

1 reference

Antonio Lopez-Beltran

series ordinal

1

1 reference

19 August 2017

1 September 2008

1 reference

Scandinavian Journal of Urology and Nephrology. Supplement

19 August 2017

1 reference

19 August 2017

95-109

1 reference

19 August 2017

218

1 reference

Bladder cancer: epidemiology, staging and grading, and diagnosis.

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Non-invasive urothelial neoplasms: according to the most recent WHO classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

The 2004 WHO classification of bladder tumors: a summary and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

The pathology of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

The pathology of bladder cancer: An update on selected issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Superficial bladder tumor. Aspects of clinical progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Asymptomatic microhematuria and urologic disease. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Time to abandon testing for microscopic haematuria in adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Morphological diagnosis of urothelial neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

On the origin of syn- and metachronous urothelial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Development and progression of urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Origin of multifocal carcinomas of the bladder and upper urinary tract: molecular analysis and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Molecular evidence supporting field effect in urothelial carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Preneoplastic non-papillary lesions and conditions of the urinary bladder: an update based on the Ancona International Consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Multivariate analysis of the prognostic factors of primary superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Urothelial papillary (exophytic) neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Low-grade Ta (noninvasive) urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Long‐term outcome of bladder papillary urothelial neoplasms of low malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Inverted papilloma of the urinary bladder: a molecular genetic appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Predicting the survival of bladder carcinoma patients treated with radical cystectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

The value of a second transurethral resection in evaluating patients with bladder tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Microscopic and gross extravesical extension in pathological staging of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Natural history of surgically treated bladder carcinoma with extravesical tumor extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Prognostic significance of vascular and perineural invasion in urothelial bladder cancer treated with radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer--analysis of role of pelvic lymph node dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03008880802325226

10.1080/03008880802325226

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18815924